We show that dietary nitrite and the ACE inhibitor captopril may be therapeutically involved in the angiotensin II type 1 receptor (Ang II -AT1R) pathway and propose a therapeutic strategy for preventing NASH development. The gene discussed is ACE; the disease is metabolic dysfunction-associated steatohepatitis.